What's breaking now, across thousands of outlets.
The restructuring comes after an unnamed "large pharmaceutical customer" terminated a contract with the company, Cellares CEO Fabian Gerlinghaus posted on LinkedIn.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Regenxbio said it no longer expects to file for FDA approval of its Hunter syndrome gene therapy in the near future after the program was slapped with its second clinical hold this year.
Salmonella is the group of bacteria behind one of the most common types of food poisoning in the UK, and while for most people it means a few unpleasant days at home, for others it can lead to serious…
(MedPage Today) -- A middle-aged man's persistent hiccups were a sign of a much more severe problem, clinicians wrote in a case report.
If you're 70 or older, or 50 or older with underlying health conditions, and have tested positive for COVID, you might have been offered free or subsidized antivirals.
Nearly half of hospitalized COVID-19 patients had a dormant virus flare back to life, and one family of viruses found in the majority of people was tied to lasting symptoms from long COVID.
COPENHAGEN, Denmark (AP) — Danish Prime Minister Mette Frederiksen is fed up with getting unsolicited beauty advice. The 48-year-old wrote Monday on Instagram that she had just returned back home from…
